Skip to main content
Top
Published in: Advances in Therapy 4/2023

Open Access 21-01-2023 | Obesity | Original Research

The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications

Authors: Hussain A. Al-Omar, Ali Alshehri, Abdulmohsen Abanumay, Hana Alabdulkarim, Ali Alrumaih, Mahmoud S. Eldin, Saleh A. Alqahtani

Published in: Advances in Therapy | Issue 4/2023

Login to get access

Abstract

Introduction

Saudi Arabia has a high prevalence of obesity, which increases the risk of individuals experiencing multiple chronic complications. Only a few publications highlight the healthcare costs of obesity-related complications (ORCs) in Saudi Arabia.

Methods

A micro-costing approach was used to estimate the healthcare costs associated with 10 ORCs. Experienced clinicians in public and private practice across different geographical regions in Saudi Arabia were asked to estimate healthcare resource use associated with each ORC, and estimated unit costs were obtained from hospital administrators. Estimated overall annual costs per patient were calculated as a weighted average of separate public and private sector costs.

Results

Individuals in Saudi Arabia with any single ORC incurred overall average annual healthcare costs of 2165–7558 US dollars (USD). Heart failure, chronic kidney disease, dyslipidemia, and type 2 diabetes (T2D) were the most costly complications, mainly driven by monitoring and/or pharmacological treatment costs. In contrast, asthma, hypertension, and angina were the least costly complications. Costs in private healthcare were higher than in public healthcare; the largest differences (2359–2793 USD) were noted for dyslipidemia, T2D, and osteoarthritis, mainly explained by differences in pharmacological treatment costs.

Conclusions

These data suggest that ORCs result in a considerable financial burden to the healthcare system, and highlight the substantial cost savings that could be achieved by preventing or delaying the occurrence of ORCs in Saudi Arabia.
Literature
2.
4.
go back to reference Balhareth A, Meertens R, Kremers S, Sleddens E. Overweight and obesity among adults in the Gulf States: a systematic literature review of correlates of weight, weight-related behaviours, and interventions. Obes Rev. 2019;20(5):763–93.CrossRefPubMedPubMedCentral Balhareth A, Meertens R, Kremers S, Sleddens E. Overweight and obesity among adults in the Gulf States: a systematic literature review of correlates of weight, weight-related behaviours, and interventions. Obes Rev. 2019;20(5):763–93.CrossRefPubMedPubMedCentral
6.
go back to reference Althumiri NA, Basyouni MH, AlMousa N, et al. Obesity in Saudi Arabia in 2020: prevalence, distribution, and its current association with various health conditions. Healthcare (Basel). 2021;9(3):311.CrossRefPubMed Althumiri NA, Basyouni MH, AlMousa N, et al. Obesity in Saudi Arabia in 2020: prevalence, distribution, and its current association with various health conditions. Healthcare (Basel). 2021;9(3):311.CrossRefPubMed
9.
go back to reference Lin X, Xu Y, Xu J, et al. Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017. Endocrine. 2020;69(2):310–20.CrossRefPubMed Lin X, Xu Y, Xu J, et al. Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990–2017. Endocrine. 2020;69(2):310–20.CrossRefPubMed
11.
go back to reference Divino V, Ramasamy A, Anupindi VR, et al. Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study. J Manag Care Spec Pharm. 2021;27(2):210–22.PubMed Divino V, Ramasamy A, Anupindi VR, et al. Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study. J Manag Care Spec Pharm. 2021;27(2):210–22.PubMed
12.
go back to reference Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30(4):251–77.CrossRefPubMed Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30(4):251–77.CrossRefPubMed
15.
go back to reference Alghnam S, Alessy SA, Bosaad M, et al. The association between obesity and chronic conditions: results from a large electronic health records system in Saudi Arabia. Int J Environ Res Public Health. 2021;18(23):12361.CrossRefPubMedPubMedCentral Alghnam S, Alessy SA, Bosaad M, et al. The association between obesity and chronic conditions: results from a large electronic health records system in Saudi Arabia. Int J Environ Res Public Health. 2021;18(23):12361.CrossRefPubMedPubMedCentral
16.
go back to reference Alqahtani SA, Saxton J, Coker T, et al. How could different obesity scenarios alter burden of diabetes and liver disease in Saudi Arabia? Poster 165: In: proceedings of the 39th Annual Meeting of the Obesity Society (Obesity Week 2021). Obesity. 2021;29(2):113. Alqahtani SA, Saxton J, Coker T, et al. How could different obesity scenarios alter burden of diabetes and liver disease in Saudi Arabia? Poster 165: In: proceedings of the 39th Annual Meeting of the Obesity Society (Obesity Week 2021). Obesity. 2021;29(2):113.
18.
go back to reference Spacirova Z, Epstein D, Garcia-Mochon L, Rovira J, Olry de Labry Lima A, Espin J. A general framework for classifying costing methods for economic evaluation of health care. Eur J Health Econ. 2020;21(4):529–42.CrossRefPubMedPubMedCentral Spacirova Z, Epstein D, Garcia-Mochon L, Rovira J, Olry de Labry Lima A, Espin J. A general framework for classifying costing methods for economic evaluation of health care. Eur J Health Econ. 2020;21(4):529–42.CrossRefPubMedPubMedCentral
19.
go back to reference Xu X, Lazar CM, Ruger JP. Micro-costing in health and medicine: a critical appraisal. Heal Econ Rev. 2021;11(1):1.CrossRef Xu X, Lazar CM, Ruger JP. Micro-costing in health and medicine: a critical appraisal. Heal Econ Rev. 2021;11(1):1.CrossRef
21.
go back to reference GBD Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.CrossRef GBD Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.CrossRef
22.
go back to reference Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes. 2021;45(6):1249–58.CrossRef Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes. 2021;45(6):1249–58.CrossRef
28.
go back to reference Nichols GA, Ustyugova A, Deruaz-Luyet A, O’Keeffe-Rosetti M, Brodovicz KG. Healthcare costs by type of expenditure across eGFR stages among patients with and without diabetes, cardiovascular disease, and heart failure. J Am Soc Nephrol. 2020;31(7):1594–601.CrossRefPubMedPubMedCentral Nichols GA, Ustyugova A, Deruaz-Luyet A, O’Keeffe-Rosetti M, Brodovicz KG. Healthcare costs by type of expenditure across eGFR stages among patients with and without diabetes, cardiovascular disease, and heart failure. J Am Soc Nephrol. 2020;31(7):1594–601.CrossRefPubMedPubMedCentral
29.
go back to reference Escobar C, Palacios B, Aranda U, et al. Costs and healthcare utilisation of patients with chronic kidney disease in Spain. BMC Health Serv Res. 2021;21(1):536.CrossRefPubMedPubMedCentral Escobar C, Palacios B, Aranda U, et al. Costs and healthcare utilisation of patients with chronic kidney disease in Spain. BMC Health Serv Res. 2021;21(1):536.CrossRefPubMedPubMedCentral
30.
go back to reference Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–56.CrossRefPubMed Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–56.CrossRefPubMed
31.
go back to reference Souliotis K, Kousoulakou H, Hillas G, et al. Direct and indirect costs of asthma management in Greece: an expert panel approach. Front Public Health. 2017;5:67.CrossRefPubMedPubMedCentral Souliotis K, Kousoulakou H, Hillas G, et al. Direct and indirect costs of asthma management in Greece: an expert panel approach. Front Public Health. 2017;5:67.CrossRefPubMedPubMedCentral
33.
go back to reference Mukherjee M, Stoddart A, Gupta RP, et al. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med. 2016;14(1):113.CrossRefPubMedPubMedCentral Mukherjee M, Stoddart A, Gupta RP, et al. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med. 2016;14(1):113.CrossRefPubMedPubMedCentral
34.
go back to reference Kerr M, Bray B, Medcalf J, O’Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27(Suppl 3):iii73–80.CrossRefPubMedPubMedCentral Kerr M, Bray B, Medcalf J, O’Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27(Suppl 3):iii73–80.CrossRefPubMedPubMedCentral
35.
go back to reference Danese MD, Gleeson M, Griffiths RI, Catterick D, Kutikova L. Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom. J Med Econ. 2017;20(9):931–7.CrossRefPubMed Danese MD, Gleeson M, Griffiths RI, Catterick D, Kutikova L. Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom. J Med Econ. 2017;20(9):931–7.CrossRefPubMed
36.
go back to reference Alzaid A, Ladron de Guevara P, Beillat M, Lehner Martin V, Atanasov P. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):785–98.CrossRefPubMed Alzaid A, Ladron de Guevara P, Beillat M, Lehner Martin V, Atanasov P. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):785–98.CrossRefPubMed
37.
go back to reference Wierzejska E, Giernas B, Lipiak A, Karasiewicz M, Cofta M, Staszewski R. A global perspective on the costs of hypertension: a systematic review. Arch Med Sci. 2020;16(5):1078–91.CrossRefPubMedPubMedCentral Wierzejska E, Giernas B, Lipiak A, Karasiewicz M, Cofta M, Staszewski R. A global perspective on the costs of hypertension: a systematic review. Arch Med Sci. 2020;16(5):1078–91.CrossRefPubMedPubMedCentral
38.
go back to reference Kirkland EB, Heincelman M, Bishu KG, et al. Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003–2014. J Am Heart Assoc. 2018;7(11):e008731.CrossRefPubMedPubMedCentral Kirkland EB, Heincelman M, Bishu KG, et al. Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003–2014. J Am Heart Assoc. 2018;7(11):e008731.CrossRefPubMedPubMedCentral
39.
go back to reference Al Mazrouei K, Almannaei AI, Nur FM, Bachnak N, Alzaabi A. Direct and indirect costs of asthma burden in Abu Dhabi: a retrospective analysis of insurance claims data from 2015 to 2018. Clinicoecon Outcomes Res. 2021;13:969–80.CrossRefPubMedPubMedCentral Al Mazrouei K, Almannaei AI, Nur FM, Bachnak N, Alzaabi A. Direct and indirect costs of asthma burden in Abu Dhabi: a retrospective analysis of insurance claims data from 2015 to 2018. Clinicoecon Outcomes Res. 2021;13:969–80.CrossRefPubMedPubMedCentral
40.
go back to reference Xie F, Kovic B, Jin X, He X, Wang M, Silvestre C. Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies. Pharmacoeconomics. 2016;34(11):1087–100.CrossRefPubMed Xie F, Kovic B, Jin X, He X, Wang M, Silvestre C. Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies. Pharmacoeconomics. 2016;34(11):1087–100.CrossRefPubMed
41.
Metadata
Title
The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications
Authors
Hussain A. Al-Omar
Ali Alshehri
Abdulmohsen Abanumay
Hana Alabdulkarim
Ali Alrumaih
Mahmoud S. Eldin
Saleh A. Alqahtani
Publication date
21-01-2023
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 4/2023
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-023-02426-z

Other articles of this Issue 4/2023

Advances in Therapy 4/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare